Institutional Biosafety Committee

SRI’s Institutional Biosafety Committee (IBC) regulates the use of biohazardous agents and recombinant DNA at SRI to assure that they are used safely and in accordance with all applicable regulations. The IBC follows NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules to provide local review and oversight of any research that is regulated by the NIH Guidelines.

Download SRI Institutional Biosafety Committee Meeting Minutes